JL Baumert, SL Taylor, SJ Koppelman. J Allergy Clin Immunol Pract. 2018;6(2):457–465.e4 To calculate the clinical benefit (risk reduction of allergic reactions) of increased peanut tolerance threshold in patients who… Click to show full abstract
JL Baumert, SL Taylor, SJ Koppelman. J Allergy Clin Immunol Pract. 2018;6(2):457–465.e4 To calculate the clinical benefit (risk reduction of allergic reactions) of increased peanut tolerance threshold in patients who are allergic, such as those who undergo peanut immunotherapy. Included in this study is a projected model of individuals with peanut allergy who consume food products with precautionary allergen labels (eg, “may contain peanut”). The authors performed quantitative risk assessment to predict the …
               
Click one of the above tabs to view related content.